Published recall report · ImpurityUpdated · 1 yr 9 mo ago
Amerisource Health Services LLC recall: Duloxetine Delayed-Release Capsules USP, 60 mg, Rx only, 30 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories NDC 68001-415-04
Duloxetine Delayed-Release Capsules USP, 60 mg, Rx only, 30 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories NDC 68001-415-04
Current recall status is unverified. FDA does not update drug-enforcement status after publication. Check the latest official information or ask a pharmacist.
What to do
Check the lot number on your pack against this recall and follow the firm's instructions. Do not stop taking a prescribed medicine without talking to a pharmacist or doctor first.
FDA public enforcement report, opens in a new tabWhich products
Duloxetine Delayed-Release Capsules USP, 60 mg, Rx only, 30 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories NDC 68001-415-04
- Producer
- Amerisource Health Services LLC
DT6023061B
- Dates on pack
- Lot DT6023061B Exp 01/31/2025
More detail
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.
In the news
Reporting from news publishers. Follow the official notice for product advice.
News is temporarily unavailable. You can still read the official warnings.